← Browse by Condition
Medical Condition
acute lymphoblastic leukemia
Total Trials
15
Recruiting Now
15
Trial Phases
Phase 2, EARLY_Phase 1, Phase 1
NCT04195633 Phase 2
Recruiting
Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies
Enrollment
60 pts
Location
United States
Sponsor
Fred Hutchinson Cancer Center
NCT05501899 EARLY_Phase 1
Recruiting
Use of Levocarnitine to Reduce Asparaginase Hepatotoxicity in Patients With Acute Lymphoblastic Leukemia
Enrollment
20 pts
Location
United States
Sponsor
Children's Hospital of Orange ...
NCT05031897 Phase 2
Recruiting
Two Step Haplo With Radiation Conditioning
Enrollment
63 pts
Location
United States
Sponsor
Thomas Jefferson University
NCT06195891 Phase 1
Recruiting
Orca-T Following Chemotherapy and Total Marrow and Lymphoid Irradiation for the Treatment of Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome
Enrollment
33 pts
Location
United States
Sponsor
City of Hope Medical Center
NCT06575296 Phase 1
Recruiting
Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant
Enrollment
27 pts
Location
United States
Sponsor
City of Hope Medical Center
NCT05334069
Recruiting
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Enrollment
2,000 pts
Location
United States
Sponsor
Alliance for Clinical Trials i...
NCT07356154 Phase 1, Phase 2
Recruiting
A Study of Revumenib and Mezigdomide in People With Leukemia
Enrollment
52 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance...
NCT05929976
Recruiting
InterNatIonal CHildhood Leukemia Microbiome/MEtabolome Cohort
Enrollment
4,900 pts
Location
United States, Brazi...
Sponsor
Columbia University
NCT05618041
Recruiting
The Safety and Efficay Investigation of CAR-T Cell Therapy for Patients With Hematological Malignancies
Enrollment
50 pts
Location
China
Sponsor
Hebei Senlang Biotechnology In...
NCT03779854 Phase 2
Recruiting
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
Enrollment
68 pts
Location
United States
Sponsor
Fred Hutchinson Cancer Center
NCT07072494 Phase 1, Phase 2
Recruiting
CD19 CAR-T Cell Infusion as Consolidation Therapy in Adolescent and Adult Patients With Acute B-ALL Ineligible for Allogeneic HSCT: A Clinical Study
Enrollment
30 pts
Location
China
Sponsor
Zhujiang Hospital
NCT05535855 Phase 1
Recruiting
UCD19 CAR T Therapy in Adults With B-ALL and MRD Positivity in CR1
Enrollment
29 pts
Location
United States
Sponsor
University of Colorado, Denver
NCT04811560 Phase 1, Phase 2
Recruiting
A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)
Enrollment
400 pts
Location
United States, Austr...
Sponsor
Janssen Research & Development...
NCT06718244 Phase 2
Recruiting
Inaticabtagene Autoleucel (Inati-cel; CNCT19) Treatment for MRD-Positive B-ALL Patients in CR1
Enrollment
20 pts
Location
China
Sponsor
Ruijin Hospital
NCT07066397 Phase 1
Recruiting
A Phase 1 Study of FIT-CD19-CAR-T Cells in R/R B-ALL
Enrollment
12 pts
Location
Taiwan
Sponsor
TriArm Therapeutics (Taiwan) L...